» Articles » PMID: 39221063

Conduction Abnormalities After Transcatheter Aortic Valve Implantation: Incidence, Impact and Management Using CT Data Interpretation

Overview
Journal Interv Cardiol
Date 2024 Sep 2
PMID 39221063
Authors
Affiliations
Soon will be listed here.
Abstract

The demonstrated safety and effectiveness of transcatheter aortic valve implantation (TAVI) among low surgical risk patients opened the road to its application in younger low-risk patients. However, the occurrence of conduction abnormalities and need for permanent pacemaker implantation remains a frequent problem associated with adverse outcomes. The clinical implications may become greater when TAVI shifts towards younger populations, highlighting the need for comprehensive strategies to address this issue. Beyond currently available clinical and electrocardiographic predictors, patient-specific anatomical assessment of the aortic root using multi-sliced CT (MSCT) imaging can refine risk stratification. Moreover, leveraging MSCT data for computational 3D simulations to predict device-anatomy interactions may help guide procedural strategy to mitigate conduction abnormalities. The aims of this review are to summarise the incidence and clinical impact of new left bundle branch block and permanent pacemaker implantation post-TAVI using contemporary transcatheter heart valves; and highlight the value of MSCT data interpretation to improve the management of this complication.

References
1.
Hamdan A, Guetta V, Klempfner R, Konen E, Raanani E, Glikson M . Inverse Relationship Between Membranous Septal Length and the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation. JACC Cardiovasc Interv. 2015; 8(9):1218-1228. DOI: 10.1016/j.jcin.2015.05.010. View

2.
Rocatello G, El Faquir N, De Santis G, Iannaccone F, Bosmans J, De Backer O . Patient-Specific Computer Simulation to Elucidate the Role of Contact Pressure in the Development of New Conduction Abnormalities After Catheter-Based Implantation of a Self-Expanding Aortic Valve. Circ Cardiovasc Interv. 2018; 11(2):e005344. DOI: 10.1161/CIRCINTERVENTIONS.117.005344. View

3.
Houthuizen P, van der Boon R, Urena M, van Mieghem N, Brueren G, Poels T . Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention. 2013; 9(10):1142-50. DOI: 10.4244/EIJV9I10A194. View

4.
Maan A, Refaat M, Heist E, Passeri J, Inglessis I, Ptaszek L . Incidence and Predictors of Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement. Pacing Clin Electrophysiol. 2015; 38(7):878-86. DOI: 10.1111/pace.12653. View

5.
Popma J, Deeb G, Yakubov S, Mumtaz M, Gada H, OHair D . Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1706-1715. DOI: 10.1056/NEJMoa1816885. View